CD93 and gastric cancer: Dong et al. conducted high-throughput RNA sequencing on clinical specimens, including primary non-metastatic gastric cancer, primary gastric cancer with peritoneal metastasis, and adjacent normal gastric mucosa, and identified CD93 as a key mRNA linked to gastric cancer peritoneal metastasis, which significantly contributes to cancer-related mortality globally [177].